Congenital Toxoplasmosis: The State of the Art
Open accessThe DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Abstract
Infection with the protozoan parasite Toxoplasma gondii occurs worldwide and usually causes no symptoms. However, a primary infection of pregnant women, may infect the fetus by transplacental transmission. The risk of mother-to-child transmission depends on week of pregnancy at the time of maternal infection: it is low in the first trimester, may reach 90% in the last days of pregnancy. Inversely, however, fetal disease is more severe when infection occurs early in pregnancy than later. Systematic serologic testing in pregnant women who have no antibodies at the beginning of pregnancy, can accurately reveal active maternal infection. Therefore, the risk of fetal infection should be assessed and preventive treatment with spiramycin must be introduced as soon as possible to reduce the risk of mother-to-child transmission, and the severity of fetal infection. When maternal infection is confirmed, prenatal diagnosis with Polymerase Chain Reaction (PCR) on amniotic fluid is recommended. If fetal infection is certain, the maternal treatment is changed to a combination of pyrimethamine-sulfonamide and folinic acid. Congenitally infected newborns are usually asymptomatic at birth, but at risk for tardive sequelae, such as blindness. When congenital infection is evident, disease include retinochoroiditis, cerebral calcifications, hydrocephalus, neurocognitive impairment. The diagnosis of congenital infection must be confirmed at birth and management, specific therapy, and follow-up with multidisciplinary counseling, must be guaranteed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Epidemiology of and Diagnostic Strategies for Toxoplasmosis
Robert-Gangneux, F., & Dardé, M.-L. (2012) · Clinical Microbiology Reviews · doi:10.1128/cmr.05013-11 · Cited by 1,815 · cited 3×
“On the contrary, the increase of IgG or the appearance of IgM and/or IgA antibodies define the congenital infection (18).”
BackgroundInfluentialThe global burden of congenital toxoplasmosis: a systematic review
Torgerson, P. R., & Mastroiacovo, P. (2013) · Bulletin of the World Health Organization · doi:10.2471/blt.12.111732 · Cited by 748
Treatment of Toxoplasmosis: Historical Perspective, Animal Models, and Current Clinical Practice
Dunay, I. R., Gajurel, K., Dhakal, R., Liesenfeld, O., & Montoya, J. G. (2018) · Clinical Microbiology Reviews · doi:10.1128/cmr.00057-17 · Cited by 553
(2007) · The Lancet · doi:10.1016/s0140-6736(07)60072-5 · Cited by 542
Infections at the maternal–fetal interface: an overview of pathogenesis and defence
Megli, C. J., & Coyne, C. B. (2022) · Nature Reviews Microbiology · doi:10.1038/s41579-021-00610-y · Cited by 442 · cited 1×
“gondii infection through the specific induction of various cytokines and chemokines, including the robust induction of the regulatory T cell chemokine (19, 20).”
BackgroundSHWAB, E. K., ZHU, X.-Q., MAJUMDAR, D., PENA, H. F. J., GENNARI, S. M., DUBEY, J. P., & SU, C. (2014) · Parasitology · doi:10.1017/s0031182013001844 · Cited by 432 · cited 1×
“The parasite genotype may play a role in determining the severity of disease: in South America the strains show greater genetic variability and are usually much more virulent (4, 5).”
BackgroundMicrobial Vertical Transmission during Human Pregnancy
Arora, N., Sadovsky, Y., Dermody, T. S., & Coyne, C. B. (2017) · Cell Host & Microbe · doi:10.1016/j.chom.2017.04.007 · Cited by 382 · cited 1×
“gondii infection through the specific induction of various cytokines and chemokines, including the robust induction of the regulatory T cell chemokine (19, 20).”
BackgroundMcLeod, R., Boyer, K., Karrison, T., Kasza, K., Swisher, C., Roizen, N., Jalbrzikowski, J., Remington, J., Heydemann, P., Noble, A. G., et al. (2006) · Clinical Infectious Diseases · doi:10.1086/501360 · Cited by 359
Ocular Sequelae of Congenital Toxoplasmosis in Brazil Compared with Europe
Gilbert, R. E., Freeman, K., Lago, E. G., Bahia-Oliveira, L. M. G., Tan, H. K., Wallon, M., Buffolano, W., Stanford, M. R., Petersen, E., & (EMSCOT), F. T. E. M. S. O. C. T. (2008) · PLoS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0000277 · Cited by 324 · cited 11×
“Brazilian infants developed chorioretinitis more frequently and the lesions are multiple, larger, and more likely located in the posterior pole than the European infants (24).”
BackgroundInfluentialDrugs in development for toxoplasmosis: advances, challenges, and current status
Alday, H., & Doggett, J. (2017) · Drug Design, Development and Therapy · doi:10.2147/dddt.s60973 · Cited by 321
Khan, A., Dubey, J. P., Su, C., Ajioka, J. W., Rosenthal, B. M., & Sibley, L. D. (2011) · International Journal for Parasitology · doi:10.1016/j.ijpara.2011.01.005 · Cited by 314
Diagnosis, Treatment, and Prevention of Congenital Toxoplasmosis in the United States
Maldonado, Y. A., Read, J. S., & COMMITTEE ON INFECTIOUS DISEASES (2017) · Pediatrics · doi:10.1542/peds.2016-3860 · Cited by 270
Global status of Toxoplasma gondii infection: systematic review and prevalence snapshots.
Molan, A., Nosaka, K., Hunter, M. L., & Wang, W. (2019) · UWA Profiles and Research Repository (UWA) · Cited by 252
Wallon, M., Peyron, F., Cornu, C., Vinault, S., Abrahamowicz, M., Kopp, C. B., & Binquet, C. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit032 · Cited by 239
Long-Term Ocular Prognosis in 327 Children With Congenital Toxoplasmosis
Wallon, M., Kodjikian, L., Binquet, C., Garweg, J., Fleury, J., Quantin, C., & Peyron, F. (2004) · Pediatrics · doi:10.1542/peds.113.6.1567 · Cited by 231 · cited 1×
“A long-term, intermittent regimen of this combination can be used in an effort to reduce the recurrence of chorioretinitis (81).”
BackgroundTreatment of toxoplasmosis: Current options and future perspectives
Konstantinovic, N., Guegan, H., Stäjner, T., Belaz, S., & Robert-Gangneux, F. (2019) · Food and Waterborne Parasitology · doi:10.1016/j.fawpar.2019.e00036 · Cited by 218
Bigna, J. J., Tochie, J. N., Tounouga, D. N., Bekolo, A. O., Ymele, N. S., Youda, E. L., Sime, P. S., & Nansseu, J. R. (2020) · Scientific Reports · doi:10.1038/s41598-020-69078-9 · Cited by 217
Cortina-Borja, M., Tan, H. K., Wallon, M., Paul, M., Prusa, A., Buffolano, W., Malm, G., Salt, A., Freeman, K., Petersen, E., et al. (2010) · PLoS Medicine · doi:10.1371/journal.pmed.1000351 · Cited by 214
Congenital toxoplasmosis: An overview of the neurological and ocular manifestations
Khan, K., & Khan, W. (2018) · Parasitology International · doi:10.1016/j.parint.2018.07.004 · Cited by 191
GRAS, L., GILBERT, R. E., WALLON, M., PEYRON, F., & CORTINA-BORJA, M. (2004) · Epidemiology and Infection · doi:10.1017/s0950268803001948 · Cited by 181
Adverse Event Profile of Pyrimethamine-Based Therapy in Toxoplasmosis: A Systematic Review
Ben-Harari, R. R., Goodwin, E., & Casoy, J. (2017) · Drugs in R&D · doi:10.1007/s40268-017-0206-8 · Cited by 180
Gras, L. A., Wallon, M., Pollak, A. J., Cortina‐Borja, M., Evengård, B., Hayde, M., Petersen, E., & Gilbert, R. E. (2005) · Acta Paediatrica · doi:10.1080/08035250500251999 · Cited by 178
Fallahi, S., Rostami, A., Nourollahpour Shiadeh, M., Behniafar, H., & Paktinat, S. (2018) · Journal of Gynecology Obstetrics and Human Reproduction · doi:10.1016/j.jogoh.2017.12.003 · Cited by 175 · cited 1×
“dilated fundoscopy (to exclude chorioretinitis, or associated ophthalmological pathologies), and transfontanellar ultrasound examination (to rule out any ventricular dilatation, cerebral calcifications, porencephaly) (64).”
BackgroundVasconcelos-Santos, D. V., Machado Azevedo, D. O., Campos, W. R., Oréfice, F., Queiroz-Andrade, G. M., Carellos, É. V. M., Castro Romanelli, R. M., Januário, J. N., Resende, L. M., & Martins-Filho, O. A. (2009) · Ophthalmology · doi:10.1016/j.ophtha.2009.04.042 · Cited by 159
Prematurity and Severity Are Associated With Toxoplasma gondii Alleles (NCCCTS, 1981–2009)
McLeod, R., Boyer, K. M., Lee, D., Mui, E., Wroblewski, K., Karrison, T., Noble, A. G., Withers, S., Swisher, C. N., Heydemann, P. T., et al. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis258 · Cited by 159 · cited 1×
“2% and atypical strains accounted for the rest (1, 2).”
BackgroundLaboratory Diagnosis of Congenital Toxoplasmosis
Pomares, C., & Montoya, J. G. (2016) · Journal of Clinical Microbiology · doi:10.1128/jcm.00487-16 · Cited by 158 · cited 2×
“However, after the third month of life, the test becomes non-specific (67).”
BackgroundAdvances in serological, imaging techniques and molecular diagnosis of Toxoplasma gondii infection
Rostami, A., Karanis, P., & Fallahi, S. (2018) · Infection · doi:10.1007/s15010-017-1111-3 · Cited by 154
Acute Toxoplasma infection in pregnant women worldwide: A systematic review and meta-analysis
Rostami, A., Riahi, S. M., Contopoulos‐Ioannidis, D. G., Gamble, H. R., Fakhri, Y., Shiadeh, M. N., Foroutan, M., Behniafar, H., Taghipour, A., Maldonado, Y., et al. (2019) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0007807 · Cited by 152
Genetic analysis of natural recombinant Brazilian Toxoplasma gondii strains by multilocus PCR–RFLP
Ferreira, A. D. M., Vítor, R. W. A., Gazzinelli, R. T., et al. (2005) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2004.12.004 · Cited by 147
Peyron, F., Lobry, J. R., Musset, K., Ferrandiz, J., Gómez‐Marín, J. E., Petersen, E., Meroni, V., Rauscher, B., Mercier, C., Picot, S., et al. (2006) · Microbes and Infection · doi:10.1016/j.micinf.2006.03.023 · Cited by 137
Self-citationToxoplasma gondii: the changing paradigm of congenital toxoplasmosis
Lindsay, D. S., & Dubey, J. P. (2011) · Parasitology · doi:10.1017/s0031182011001478 · Cited by 107
The Austrian Toxoplasmosis Register, 1992-2008
Prusa, A. R., Kasper, D. C., Pollak, A. J., Gleiß, A., Waldhoer, T., & Hayde, M. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu724 · Cited by 105 · cited 2×
“The prenatal screening allows to identify anti-toxoplasma IgG seronegative women at risk of acquiring the infection in which the primary prevention is mandatory (5, 13, 44, 45).”
BackgroundVaudaux, J. D., Muccioli, C., James, E. R., Silveira, C., Magargal, S. L., Jung, C., Dubey, J. P., Jones, J. L., Doymaz, M. Z., Bruckner, D. A., et al. (2010) · The Journal of Infectious Diseases · doi:10.1086/656397 · Cited by 104
Prenatal education for congenital toxoplasmosis
Mario, S. D., Basevi, V., Gagliotti, C., Spettoli, D., Gori, G., D’Amico, R., & Magrini, N. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006171.pub4 · Cited by 102 · cited 1×
“Randomized controlled trials have shown little evidence that prenatal education has a positive effect in reducing seroconversion for toxoplasmosis in pregnancy (92).”
BackgroundTreatments for toxoplasmosis in pregnancy
Peyron, F., Wallon, M., Liou, C., & Garner, P. (1999) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001684 · Cited by 102 · cited 1×
“Treatment of Toxoplasma gondii Infection During Pregnancy There are many discrepancies in studies published between 1999 and 2006 on the efficacy of prenatal treatment in reducing the incidence and severity of congenital toxoplasmosis (55, 56).”
BackgroundA systematic review of neonatal toxoplasmosis exposure and sensorineural hearing loss
Brown, E. D., Chau, J. K., Atashband, S., Westerberg, B. D., & Kozak, F. K. (2009) · International Journal of Pediatric Otorhinolaryngology · doi:10.1016/j.ijporl.2009.01.012 · Cited by 89 · cited 1×
“gondii infection in pregnancy and hearing loss in offspring is recorded (85, 86).”
BackgroundDiscovery of New Inhibitors of Toxoplasma gondii via the Pathogen Box
Spalenka, J., Escotte‐Binet, S., Bakiri, A., Hubert, J., Renault, J., Velard, F., Duchateau, S., Aubert, D., Huguenin, A., & Villena, I. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01640-17 · Cited by 81
Gollub, E. L., Leroy, V., Gilbert, R. E., Chêne, G., & Wallon, M. (2007) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2007.09.010 · Cited by 79 · cited 1×
“Dietary recommendations and behavioral factors, including pet care and environmental measures, can help to reduce the risk of acquiring toxoplasmosis in pregnant women or women of childbearing age (91).”
BackgroundMalan, V., Bussières, L., Winer, N., Jaïs, J., Baptiste, A., Lorc’h, M. L., Elie, C., O’Gorman, N., Fries, N., Houfflin‐Debarge, V., et al. (2018) · JAMA · doi:10.1001/jama.2018.9396 · Cited by 79
No. 285-Toxoplasmosis in Pregnancy: Prevention, Screening, and Treatment
Paquet, C., & Yudin, M. H. (2018) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/j.jogc.2018.05.036 · Cited by 76
Long-term ocular outcome in congenital toxoplasmosis: A prospective cohort of treated children
Faucher, B., Garcia-Méric, P., Franck, J., Minodier, P., Francois, P., Gonnet, S., L’Ollivier, C., & Piarroux, R. (2011) · Journal of Infection · doi:10.1016/j.jinf.2011.10.008 · Cited by 70
The cost-effectiveness of neonatal versus prenatal screening for congenital toxoplasmosis
Binquet, C., Lejeune, C., Seror, V., Peyron, F., Bertaux, A.-C., Scemama, O., Quantin, C., Béjean, S., Stillwaggon, E. M., & Wallon, M. (2019) · PLoS ONE · doi:10.1371/journal.pone.0221709 · Cited by 56 · cited 2×
“The prenatal screening allows to identify anti-toxoplasma IgG seronegative women at risk of acquiring the infection in which the primary prevention is mandatory (5, 13, 44, 45).”
BackgroundPleyer, U., Groß, U., Schlüter, D., et al. (2019) · PubMed · doi:10.3238/arztebl.2019.0435 · Cited by 54
Current treatment of ocular toxoplasmosis in immunocompetent patients: a network meta-analysis
Zhang, Y., Lin, X., & Lü, F. (2018) · Acta Tropica · doi:10.1016/j.actatropica.2018.04.026 · Cited by 52
Pernas, L. F., Ramirez, R., Holmes, T. H., Montoya, J. G., & Boothroyd, J. C. (2014) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiu189 · Cited by 44
In Utero and at Birth Diagnosis of Congenital Toxoplasmosis
Rabilloud, M., Wallon, M., & Peyron, F. (2010) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e3181c80493 · Cited by 43
Dhombres, F., Friszer, S., Maurice, P., Gonzalès, M., Kieffer, F., Garel, C., & Jouannic, J. (2016) · Fetal Diagnosis and Therapy · doi:10.1159/000445113 · Cited by 36 · cited 1×
“The interaction between physicians and families is always important in managing a pregnancy complicated by fetal infection, termination of pregnancy is to be discouraged unless, in the opinion of experts, there is evidence of serious sequelae affecting the fetus (17, 63).”
BackgroundSaso, A., Bamford, A., Grewal, K. J., et al. (2020) · Archives of Disease in Childhood Education & Practice · doi:10.1136/archdischild-2018-316603 · Cited by 31
Therapy for Ocular Toxoplasmosis – The Future
Garweg, J. G., & Stanford, M. R. (2013) · Ocular Immunology and Inflammation · doi:10.3109/09273948.2013.779724 · Cited by 28 · cited 1×
“In a prospective cohort study on 3 years old children with congenital toxoplasmosis, more than 90% of children with chorioretinitis had normal vision in the best eye, and only 9% had severe bilateral impairment (78).”
BackgroundAjzenberg, D. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis264 · Cited by 24
Moodley, A., & Payton, K. S. E. (2021) · Clinics in Perinatology · doi:10.1016/j.clp.2021.05.004 · Cited by 19
Metadata
- Authors
- Bollani, L., Auriti, C., Achille, C., Garofoli, F., De Rose, D. U., Meroni, V., Salvatori, G., & Tzialla, C.
- Venue
- Frontiers in Pediatrics
- Publisher
- Frontiers Media SA
- Published
- 2022-07-06
- Volume
- 10
- Pages
- 894573-894573
- ISSN
- 2296-2360 (ISSN-L)
- OpenAlex
- W4286615913
- Cited by
- 176
- References
- 51
- FWCI
- 20.61
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.